7251 - 7275 of 9145 Results
Title
Year
-
OPENTitle: Impact of Y chromosome loss on the risk of Parkinson's disease and progressionJournal Name: eBioMedicinePublisher: Elsevier BVVol: 117Issue #:Start Page: 105769End Page: 105769Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105769Best OA location URL: https://www.thelancet.com/action/showPdf?pii=S2352396425002130Citation Count: 4
-
OPENTitle: Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global ConferenceJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 5Start Page: e70078End Page: e70078Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/alz.70078Best OA location URL: https://doi.org/10.1002/alz.70078Citation Count: 6
-
OPENTitle: Cognitive impairment and dementia in Latin American individuals with parkinsonism and Parkinson's disease: A 10/66 Dementia Research Group studyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 7Start Page: e70371End Page: e70371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.70371Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70371Citation Count: 1
-
OPENTitle: Novel early‐onset Alzheimer‐associated genes influence risk through dysregulation of glutamate, immune activation, and intracellular signaling pathwaysJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 6Start Page: e70377End Page: e70377Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.70377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70377Citation Count: 7
-
OPENTitle: Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease: The FIRE-UP PD studyJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 144Issue #:Start Page: 107619End Page: 107619Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cct.2024.107619Best OA location URL: https://doi.org/10.1016/j.cct.2024.107619Citation Count: 8
- LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits2020RESTRICTEDTitle: LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 12Issue #: 540Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aav0820Citation Count: 131
-
OPENTitle: Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s diseaseJournal Name: Journal of Medical GeneticsPublisher: BMJVol: 57Issue #: 5Start Page: 331End Page: 338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jmedgenet-2019-106283Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8474559Citation Count: 71
-
OPENTitle: Incidence of Parkinson disease in North AmericaJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 170End Page: 170Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00410-yBest OA location URL: https://www.nature.com/articles/s41531-022-00410-y.pdfCitation Count: 320
-
OPENTitle: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleusJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 24Start Page: e112006End Page: e112006Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2022112006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2022112006Citation Count: 35
-
OPENTitle: Precision medicine for Parkinson’s disease: The subtyping challengeJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 1064057End Page: 1064057Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1064057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1064057/pdfCitation Count: 17
-
OPENTitle: LRP1: a novel receptor for the transmission of pathological α-SynucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page: 79End Page: 79Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00582-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00582-4Citation Count: 6
- Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s Disease2022OPENTitle: Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14018End Page: 14018Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214018Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14018/pdf?version=1668398534Citation Count: 23
-
OPENTitle: Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutantsJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 12Start Page: 102565End Page: 102565Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2022.102565Best OA location URL: http://www.jbc.org/article/S0021925822010092/pdfCitation Count: 7
-
OPENTitle: Digitizing a Therapeutic: Development of an Augmented Reality Dual-Task Training Platform for Parkinson’s DiseaseJournal Name: SensorsPublisher: MDPI AGVol: 22Issue #: 22Start Page: 8756End Page: 8756Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s22228756Best OA location URL: https://www.mdpi.com/1424-8220/22/22/8756/pdf?version=1668248220Citation Count: 10
-
OPENTitle: The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 1049118End Page: 1049118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.1049118Best OA location URL: https://doi.org/10.3389/fnins.2022.1049118Citation Count: 5
-
OPENTitle: Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian AmazonJournal Name: PLOS Neglected Tropical DiseasesPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 11Start Page: e0010773End Page: e0010773Publication Date:Open Access(OA) Status: OPENLicense: cc0, cc0DOI - Digital Object Identifier: 10.1371/journal.pntd.0010773Best OA location URL: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0010773&type=printableCitation Count: 9
- Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism2022OPENTitle: Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonismJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 182Issue #:Start Page: 106338End Page: 106338Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2022.106338Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9733952Citation Count: 12
-
OPENTitle: Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficitJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 1048945End Page: 1048945Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.1048945Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.1048945/pdfCitation Count: 5
-
OPENTitle: Adult-onset KMT2B-related dystoniaJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page: fcac276End Page: fcac276Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac276Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/6/fcac276/47057049/fcac276.pdfCitation Count: 14
-
OPENTitle: No Evidence for a Causal Relationship Between Cancers and Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 2Start Page: 801End Page: 809Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202474Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9719261Citation Count: 12
-
OPENTitle: Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2257End Page: 2262Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29189Citation Count: 27
-
OPENTitle: Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic TherapyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 15End Page: 23Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000525664Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9671814Citation Count: 3
-
OPENTitle: Universal clinical Parkinson’s disease axes identify a major influence of neuroinflammationJournal Name: Genome MedicinePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 129End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13073-022-01132-9Best OA location URL: https://genomemedicine.biomedcentral.com/counter/pdf/10.1186/s13073-022-01132-9Citation Count: 18
-
OPENTitle: Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisomeJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 174End Page: 174Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-022-01113-5Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-022-01113-5Citation Count: 191
-
OPENTitle: Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2301End Page: 2307Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29220Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29220Citation Count: 30